+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Radiation Oncology Market - Global Forecast 2026-2032- Product Image
Radiation Oncology Market - Global Forecast 2026-2032- Product Image
New

Radiation Oncology Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 183 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968884
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The radiation oncology market is in a state of rapid evolution, driven by technology integration, value-focused decision-making, and the emergence of diverse care delivery models. Senior decision-makers must evaluate clinical and operational priorities to direct technology investment, streamline workflows, and address complex procurement dynamics within a changing landscape.

Market Snapshot: Radiation Oncology Market Growth Trajectory

The global radiation oncology market is demonstrating sustained momentum, advancing from USD 15.34 billion in 2025 to USD 16.39 billion in 2026, with projections pointing to USD 28.13 billion by 2032. This growth, reflected in a compound annual growth rate of 9.04%, is primarily influenced by accelerating adoption of novel therapy platforms, innovative clinical workflows, and adjustments required for changing regulatory frameworks. Regional differences in healthcare infrastructure, cost-containment policies, and procurement strategies are also helping to shape adoption patterns as stakeholders pursue both advanced treatment capabilities and operational efficiency.

Scope & Segmentation of the Radiation Oncology Market

  • Technology Variants: Includes brachytherapy (both high and low dose rate), intensity modulated radiation therapy, proton therapy using passive scattering and pencil beam scanning, stereotactic body radiotherapy, and three dimensional conformal techniques, ensuring treatment protocols for a wide range of oncology cases.
  • Component Distinctions: Encompasses hardware configurations and specialized software for treatment planning and analytics, as well as services that support clinical operations and enhance holistic care delivery across different settings.
  • Delivery Modes: Features external beam therapies, intraoperative approaches, and hybrid models that enable integration within multi-disciplinary care teams, delivered through both conventional and emerging digital channels.
  • Clinical Applications: Addresses the management of breast, head and neck, lung, and prostate cancers—tailoring technology to match the clinical requirements of each primary indication for improved outcomes.
  • End-User Operational Profiles: Reflects the distinct needs of ambulatory surgical centers, standalone cancer clinics, and hospitals, each presenting unique workflow, staffing, and infrastructure demands that shape procurement and deployment of technologies.
  • Region Coverage: Provides insight into the Americas, Europe, Middle East and Africa, and Asia-Pacific, highlighting how regulatory climates, procurement practices, and workforce capabilities influence market opportunities and technology uptake.

Key Takeaways for Senior Decision-Makers

  • Integrated software platforms and device ecosystems elevate clinical precision and support robust patient management, with interoperability now a critical factor influencing investment and vendor selection.
  • Effective procurement strategies address not just equipment performance, but also lifecycle flexibility, future upgrade potential, and service models synchronizing with changing operational requirements.
  • Adopting advanced treatment modalities requires attention to workforce skill development, capital allocation, and establishing collaborative partnerships to ensure enduring technology sustainability.
  • Hybrid models, which combine centralized infrastructure with remote digital planning, extend provider reach and facilitate operational efficiency across multiple clinical sites.
  • Treatment personalization—ranging from hypofractionation for certain indications to precision-guided protocols for complex disease types—drives provider differentiation and informs technology choices.

Tariff Impact on Procurement and Vendor Strategy

Recent changes in import duties and trade policies have impacted procurement planning for radiation oncology assets. To mitigate these pressures, procurement leaders are considering flexible contract structures, opting for modular equipment investments, and phasing capital deployments. Vendor responses include introducing adaptive pricing models, expanding local assembly, and enhanced managed equipment services—enabling healthcare organizations to better manage price volatility and strategically plan investments.

Methodology & Data Sources

This analysis builds on primary interviews with clinical specialists, physicists, procurement experts, and industry vendors. Supplementary sources include peer-reviewed clinical studies, up-to-date medical guidelines, regulatory materials, and detailed product specifications. Comparative assessments and segmentation analyses contextualize technology and operational priorities across all regions.

Why This Report Matters

  • Comprehensive market analysis empowers executive teams to make informed technology adoption and procurement decisions grounded in transparent risks and trends.
  • Alignment of clinical, operational, and procurement objectives supports effective capital deployment and enables workforce strategies that match evolving market conditions.
  • Actionable guidance prepares organizations to respond efficiently to regulatory or tariff changes, building resilience and agility into long-term decision frameworks.

Conclusion

This report serves as a reference for senior leaders developing technology strategies, optimizing vendor engagement, and designing care models equipped to adapt to future market and regulatory shifts.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Radiation Oncology Market, by Technology
8.1. Brachytherapy
8.1.1. High Dose Rate
8.1.2. Low Dose Rate
8.2. Intensity Modulated Radiation Therapy
8.2.1. Step And Shoot Imrt
8.2.2. Volumetric Modulated Arc Therapy
8.3. Proton Therapy
8.3.1. Passive Scattering
8.3.2. Pencil Beam Scanning
8.4. Stereotactic Body Radiotherapy
8.4.1. Cyberknife
8.4.2. Linac Based
8.5. Three Dimensional Conformal Radiation Therapy
9. Radiation Oncology Market, by Component
9.1. Hardware
9.2. Services
9.3. Software
10. Radiation Oncology Market, by Delivery Mode
10.1. External Beam
10.1.1. Rotational Beam
10.1.2. Stationary Beam
10.2. Intraoperative
10.2.1. Minimally Invasive
10.2.2. Open Surgery
11. Radiation Oncology Market, by Application
11.1. Breast Cancer
11.2. Head And Neck Cancer
11.3. Lung Cancer
11.4. Prostate Cancer
12. Radiation Oncology Market, by End User
12.1. Ambulatory Surgical Centers
12.1.1. Freestanding
12.1.2. Hospital Affiliated
12.2. Cancer Treatment Centers
12.2.1. Multispecialty
12.2.2. Standalone
12.3. Hospitals
12.3.1. Private
12.3.2. Public
13. Radiation Oncology Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Radiation Oncology Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Radiation Oncology Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Radiation Oncology Market
17. China Radiation Oncology Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Accuray Incorporated
18.6. Bayer AG
18.7. Best Medical International, Inc.
18.8. Canon Medical Systems Corporation
18.9. Elekta AB
18.10. Hitachi, Ltd.
18.11. Ion Beam Applications SA
18.12. Isoray, Inc.
18.13. Mevion Medical Systems, Inc.
18.14. Novartis AG
18.15. Panacea Medical Technologies Pvt. Ltd.
18.16. RefleXion Medical, Inc.
18.17. Siemens Healthineers AG
18.18. Varian Medical Systems, Inc.
18.19. ViewRay, Inc.
List of Figures
FIGURE 1. GLOBAL RADIATION ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL RADIATION ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL RADIATION ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA RADIATION ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL RADIATION ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY HIGH DOSE RATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY HIGH DOSE RATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY HIGH DOSE RATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY LOW DOSE RATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY LOW DOSE RATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY LOW DOSE RATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY STEP AND SHOOT IMRT, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY STEP AND SHOOT IMRT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY STEP AND SHOOT IMRT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY VOLUMETRIC MODULATED ARC THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY VOLUMETRIC MODULATED ARC THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY VOLUMETRIC MODULATED ARC THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PASSIVE SCATTERING, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PASSIVE SCATTERING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PASSIVE SCATTERING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PENCIL BEAM SCANNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PENCIL BEAM SCANNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PENCIL BEAM SCANNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY CYBERKNIFE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY CYBERKNIFE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY CYBERKNIFE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY LINAC BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY LINAC BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY LINAC BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY THREE DIMENSIONAL CONFORMAL RADIATION THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY THREE DIMENSIONAL CONFORMAL RADIATION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY THREE DIMENSIONAL CONFORMAL RADIATION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY ROTATIONAL BEAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY ROTATIONAL BEAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY ROTATIONAL BEAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY STATIONARY BEAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY STATIONARY BEAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY STATIONARY BEAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY HEAD AND NECK CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY HEAD AND NECK CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY HEAD AND NECK CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY FREESTANDING, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY FREESTANDING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY FREESTANDING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY HOSPITAL AFFILIATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY HOSPITAL AFFILIATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY MULTISPECIALTY, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY MULTISPECIALTY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY MULTISPECIALTY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY STANDALONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY STANDALONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY STANDALONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2032 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 182. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 184. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
TABLE 185. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 186. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2032 (USD MILLION)
TABLE 187. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 188. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 189. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 190. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2018-2032 (USD MILLION)
TABLE 191. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2018-2032 (USD MILLION)
TABLE 192. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 193. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 195. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2032 (USD MILLION)
TABLE 196. EUROPE RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 199. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 201. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2032 (USD MILLION)
TABLE 202. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 212. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 214. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
TABLE 215. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 216. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2032 (USD MILLION)
TABLE 217. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 218. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 219. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 220. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2018-2032 (USD MILLION)
TABLE 221. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2018-2032 (USD MILLION)
TABLE 222. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 223. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 225. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2032 (USD MILLION)
TABLE 226. AFRICA RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 227. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 228. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 229. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
TABLE 230. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 231. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2032 (USD MILLION)
TABLE 232. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 233. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 234. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2018-2032 (USD MILLION)
TABLE 236. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2018-2032 (USD MILLION)
TABLE 237. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 238. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 239. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 240. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2032 (USD MILLION)
TABLE 241. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 242. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 243. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 244. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 245. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
TABLE 246. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 247. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2032 (USD MILLION)
TABLE 248. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 249. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 250. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 251. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2018-2032 (USD MILLION)
TABLE 252. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2018-2032 (USD MILLION)
TABLE 253. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 254. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 255. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 256. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2032 (USD MILLION)
TABLE 257. ASEAN RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 258. GCC RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. GCC RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 260. GCC RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
TABLE 261. GCC RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 262. GCC RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2032 (USD MILLION)
TABLE 263. GCC RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 264. GCC RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 265. GCC RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 266. GCC RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2018-2032 (USD MILLION)
TABLE 267. GCC RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2018-2032 (USD MILLION)
TABLE 268. GCC RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 269. GCC RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 270. GCC RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 271. GCC RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2032 (USD MILLION)
TABLE 272. GCC RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 279. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 281. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2018-2032 (USD MILLION)
TABLE 282. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2018-2032 (USD MILLION)
TABLE 283. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 284. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 285. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 286. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2032 (USD MILLION)
TABLE 287. EUROPEAN UNION RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 288. BRICS RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 289. BRICS RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 290. BRICS RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
TABLE 291. BRICS RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 292. BRICS RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2032 (USD MILLION)
TABLE 293. BRICS RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 294. BRICS RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 295. BRICS RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 296. BRICS RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2018-2032 (USD MILLION)
TABLE 297. BRICS RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2018-2032 (USD MILLION)
TABLE 298. BRICS RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 299. BRICS RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 300. BRICS RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 301. BRICS RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2032 (USD MILLION)
TABLE 302. BRICS RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 303. G7 RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 304. G7 RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 305. G7 RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
TABLE 306. G7 RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 307. G7 RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2032 (USD MILLION)
TABLE 308. G7 RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 309. G7 RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 310. G7 RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 311. G7 RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2018-2032 (USD MILLION)
TABLE 312. G7 RADIATION ONCOLOGY MARKET SIZE, BY INTRAOPERATIVE, 2018-2032 (USD MILLION)
TABLE 313. G7 RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 314. G7 RADIATION ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 315. G7 RADIATION ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
TABLE 316. G7 RADIATION ONCOLOGY MARKET SIZE, BY CANCER TREATMENT CENTERS, 2018-2032 (USD MILLION)
TABLE 317. G7 RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 318. NATO RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 319. NATO RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 320. NATO RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2032 (USD MILLION)
TABLE 321. NATO RADIATION ONCOLOGY MARKET SIZE, BY INTENSITY MODULATED RADIATION THERAPY, 2018-2032 (USD MILLION)
TABLE 322. NATO RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2032 (USD MILLION)
TABLE 323. NATO RADIATION ONCOLOGY MARKET SIZE, BY STEREOTACTIC BODY RADIOTHERAPY, 2018-2032 (USD MILLION)
TABLE 324. NATO RADIATION ONCOLOGY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 325. NATO RADIATION ONCOLOGY MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 326. NATO RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM, 2018-2032 (USD MILLION)
TABLE 327. NATO RADIATION ONCOLOGY MARKET SIZ

Companies Mentioned

The key companies profiled in this Radiation Oncology market report include:
  • Accuray Incorporated
  • Bayer AG
  • Best Medical International, Inc.
  • Canon Medical Systems Corporation
  • Elekta AB
  • Hitachi, Ltd.
  • Ion Beam Applications SA
  • Isoray, Inc.
  • Mevion Medical Systems, Inc.
  • Novartis AG
  • Panacea Medical Technologies Pvt. Ltd.
  • RefleXion Medical, Inc.
  • Siemens Healthineers AG
  • Varian Medical Systems, Inc.
  • ViewRay, Inc.

Table Information

Report AttributeDetails
No. of Pages183
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 16.39 Billion
Forecasted Market Value ( USD ) by 2032 $ 28.13 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Radiation Oncology - Global Strategic Business Report - Product Image

Radiation Oncology - Global Strategic Business Report

  • Report
  • 488 Pages
  • Global
From
Radiation Oncology Market Report by Type, Technology, Application, End User, and Region 2025-2033 - Product Image

Radiation Oncology Market Report by Type, Technology, Application, End User, and Region 2025-2033

  • Report
  • 137 Pages
  • Global
From
Radiation Oncology Market Size, Share & Trends Analysis Report by Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), Technology, Application, and Region with Growth Forecasts, 2025-2030 - Product Image

Radiation Oncology Market Size, Share & Trends Analysis Report by Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), Technology, Application, and Region with Growth Forecasts, 2025-2030

  • Report
  • 130 Pages
  • Global
From
Radiation Oncology Treatment Planning Software Market Report 2025 - Product Image

Radiation Oncology Treatment Planning Software Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Radiation Therapy Equipment Market - Global Forecast 2026-2032 - Product Image

Radiation Therapy Equipment Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From

About the Market

Radiation Oncology is a branch of Oncology Drugs that uses radiation to treat cancer. It is a form of cancer treatment that uses high-energy radiation to kill cancer cells and shrink tumors. Radiation therapy is used to treat a variety of cancers, including breast, prostate, lung, and brain cancer. It is often used in combination with other treatments, such as chemotherapy and surgery. Radiation therapy works by damaging the DNA of cancer cells, which prevents them from growing and dividing. Radiation Oncology is a rapidly growing field, with new technologies and treatments being developed to improve outcomes for patients. It is an important part of the overall cancer treatment landscape, and is often used in combination with other treatments to maximize the effectiveness of cancer treatment. Some companies in the Radiation Oncology market include Varian Medical Systems, Elekta, Accuray, and IBA. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.